Farid Kia, MD
Pain Medicine · Camarillo, CANPI 1902053663
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 58 manufacturers reported payments, led by Boston Scientific at 26.2% of the total. 2025 is the largest year on record at $20,775, 3.5 times the $5,873 reported in 2019. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,163 payments — averaging $55.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$17K
- Biotronik NRO, Inc.$14K
- Medtronic$5K
- Abbott$5K
- Nevro Corp.$5K
- Saluda Medical Americas, Inc.$3K
- plus $16K from 52 others
Across 1 payment — averaging $460.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$460
What the payments were for
- Speaking & faculty fees$23,70537%
- Travel & lodging$5,1318%
- Food & beverage$36,01356%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$14,027
- Prospera$11,684
- Senza Spinal Cord Stimulation System$2,145
- Evoke SCS$1,624
- Proclaim Family of SCS IPGs$1,031
- INTELLIS ADAPTIVESTIM$1,027
- Proclaim IPG$913
- PROCLAIM$587
- Senza$419
- Evoke$387
- Accurian$386
- ReActiv8$341
- Omnia$339
- SPRINT PNS System$289
- PAINTEQ$247
- AIMOVIG$241
- Penta SCS Leads$175
- Neuromodulation Dspsbls and Accs$170
- mild Device Kit$138
- IonicRF$134
How this compares
$64,849 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 913 | $24,733 |
| BotoxOnabotulinumtoxina | 18 | $22,443 |
| BelbucaBuprenorphine Hcl | 35 | $15,075 |
| Aimovig AutoinjectorErenumab-Aooe | 21 | $15,000 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 291 | $14,044 |
| Buprenorphine | 36 | $10,492 |
| Emgality PenGalcanezumab-Gnlm | 12 | $8,039 |
| Gabapentin | 351 | $6,189 |
| Lidocaine | 36 | $4,648 |
| Oxycodone Hcl | 226 | $4,456 |
| ZtlidoLidocaine | 13 | $4,390 |
| Pregabalin | 184 | $2,546 |
| Tramadol Hcl | 202 | $2,213 |
| Cyclobenzaprine Hcl | 206 | $1,736 |
| Tramadol Hcl ErTramadol Hcl | 29 | $1,687 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $1,838 | $22,44318 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $742 | $15,07535 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $457 | $4,39013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 840 pain medicine providers in California.
Other pain medicine in Camarillo
- Caitlin TourjeCamarillo$80K
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.